Alphatec Holdings, Inc. SEC 10-Q Report

Alphatec Holdings, Inc., a leading provider of spinal surgery implants and medical imaging equipment, has released its Form 10-Q report for the third quarter of 2025. The report showcases significant improvements in both financial and operational metrics, reflecting the company's ongoing efforts to expand its market presence and enhance its product offerings.

Financial Highlights

• Revenue from products and services: $196.5 million, increased by 30% compared to the same period in 2024, primarily due to an increase in product volume and expansion of the surgeon user base.
• Gross Profit: $137.3 million, reflecting a strong margin driven by increased product volume.
• Operating Loss: $(15.9) million, improved from $(33.7) million in the same period in 2024, indicating better operational efficiency.
• Net Loss: $(28.6) million, compared to $(39.6) million in the same period in 2024, showing a reduction in losses.
• Net Loss Per Share, basic and diluted: $(0.19), compared to $(0.28) in the same period in 2024, reflecting improved financial performance.

Business Highlights

• Revenue Segments: The company derives its revenue primarily from the sale of spinal surgery implants and medical imaging equipment. Spinal implant products include pedicle screws, interbody devices, plates, and tissue-based materials, while medical imaging equipment includes EOS full-body and weight-bearing x-ray imaging devices.
• Geographical Performance: The United States remains the primary market, contributing significantly to the company's revenue with $184.4 million for the three months ended September 30, 2025. International markets also showed growth, with revenue increasing to $12.1 million for the same period.
• Sales Units: The increase in product volume was driven by an expanding surgeon user base and the adoption of new products, contributing to the overall revenue growth.
• New Product Launches: The company continues to expand its product portfolio, focusing on innovative technologies that integrate with its InformatiX™ product platform to enhance surgical outcomes.
• Future Outlook: The company plans to continue its investment in building a strategic distribution channel and expanding its sales team to reach untapped markets and better penetrate existing accounts. The focus remains on revolutionizing spine surgery through clinical distinction and expanding market share.

SEC Filing: Alphatec Holdings, Inc. [ ATEC ] - 10-Q - Oct. 30, 2025